首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   459279篇
  免费   47009篇
  国内免费   201篇
  2018年   4261篇
  2016年   5388篇
  2015年   6747篇
  2014年   8010篇
  2013年   12255篇
  2012年   14080篇
  2011年   14844篇
  2010年   9614篇
  2009年   8477篇
  2008年   13071篇
  2007年   13815篇
  2006年   12948篇
  2005年   12217篇
  2004年   12230篇
  2003年   11865篇
  2002年   11673篇
  2001年   18565篇
  2000年   18691篇
  1999年   14814篇
  1998年   5387篇
  1997年   5612篇
  1996年   5394篇
  1995年   5064篇
  1994年   4980篇
  1993年   4928篇
  1992年   12670篇
  1991年   12428篇
  1990年   12412篇
  1989年   12154篇
  1988年   11448篇
  1987年   10792篇
  1986年   10085篇
  1985年   10552篇
  1984年   8804篇
  1983年   7589篇
  1982年   5928篇
  1981年   5305篇
  1980年   4929篇
  1979年   8335篇
  1978年   6536篇
  1977年   6177篇
  1976年   5888篇
  1975年   6397篇
  1974年   6913篇
  1973年   6766篇
  1972年   6248篇
  1971年   5687篇
  1970年   4884篇
  1969年   4894篇
  1968年   4565篇
排序方式: 共有10000条查询结果,搜索用时 62 毫秒
991.
992.
N.m.r. studies of metabolism in perfused organs   总被引:1,自引:0,他引:1  
Several metabolites and intracellular pH in intact organs can be studied in a non-destructive manner by phorphorus nuclear magnetic resonance (31P n.m.r.). This possibility was demonstrated by us nearly five years ago. Since then we have developed the appropriate physiological techniques and improved the n.m.r. method for the study of animal hearts and kidneys. Here we described measurements aimed at clarifying three problesm. (1) Having measured the enzyme-catalysed fluxes between phosphocreatine and ATP by the method of saturation transfer n.m.r., we examine the relations between energy supply and heart rate in the isolated perfused rat heart. (2) We describe experiments to establish the validity of the perfusion model. For the first time, we report 31P n.m.r. measurements of an in vivo rat heart and compare the results with those obtained for the perfused rat heart. (3) Ischaemia and metabolism in rabbit kidneys is investigated to establish the relation between functional and metabolic recovery after a renal transplant operation.  相似文献   
993.
994.
995.
996.
997.
998.
Monocytes/macrophages play a critical role in the initiation and progression of a variety of glomerulonephritides. We sought to define the interactions between physiologically activated human monocytes and glomerular mesangial cells (MC) by employing a cell culture system that permits the accurate assessment of the contribution of soluble factors and cell-to-cell contact. Human peripheral blood monocytes, primed with IFN-gamma and GM-CSF, were activated with CD40 ligand (CD40L) or TNF-alpha and cocultured with MC. CD40L-activated monocytes induced higher levels of IL-6, monocyte chemoattractant protein-1 (MCP-1) and ICAM-1 synthesis by MC. Separation of CD40L-activated monocytes from MC by a porous membrane decreased the mesangial synthesis of IL-6 by 80% and ICAM-1 by 45%, but had no effect on MCP-1. Neutralizing Abs against the beta 2 integrins, LFA-1 and Mac-1, decreased IL-6 production by 40 and 50%, respectively. Ligation of mesangial surface ICAM-1 directly enhanced IL-6, but not MCP-1, production. Simultaneous neutralization of soluble TNF-alpha and IL-1 beta decreased MCP-1 production by 55% in membrane-separated cocultures of MC/CD40L-activated monocytes. Paraformaldehyde-fixed CD40L-activated monocytes (to preserve membrane integrity but prevent secretory activity), cocultured with MC at various ratios, induced IL-6, MCP-1, and ICAM-1 synthesis by MC. Plasma membrane preparations from activated monocytes also induced mesangial IL-6 and MCP-1 synthesis. The addition of plasma membrane enhanced TNF-alpha-induced mesangial IL-6 production by approximately 4-fold. Together, these data suggest that the CD40/CD40L is essential for optimal effector function of monocytes, that CD40L-activated monocytes stimulate MC through both soluble factors and cell-to-cell contact mediated pathways, and that both pathways are essential for maximum stimulation of MC.  相似文献   
999.
1000.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号